Latest News Feed
Uploaded
08-30-2026
ESC 2026 Impact Meter Highlights: Prof Nicole Karam on Practice-Changing Valvular Heart Disease Data
ESC 2026 Impact Meter Highlights: Prof Nicole Karam on Practice-Changing Valvular Heart Disease Data What were the bigges ...
Tweeted
08-30-2026
Radcliffe Cardiology
@radcliffeCARDIO 💊“This was a perfect study designed to test a policy intervention.” At #ESCCongress 2026, Dr Harriette Van Spall (@hvanspall) speaks with Prof Elmir Omerovic (@elmir1omerovic) about #SWITCHSWEDEHEART. 📊 Deathpall (@hvanspall) speaks with Prof Elmir Omerovic (@elmir1omerovic) about #SWITCHSWEDEHEART. 📊 Death, MI or stroke at 1 year: • 11.1% with a prasugr.co/70SZ0BK1uE
Radcliffe Cardiology
@radcliffeCARDIO 💊“This was a perfect study designed to test a policy intervention.” At #ESCCongress 2026, Dr Harriette Van Spall (@hvanspall) speaks with Prof Elmir Omerovic (@elmir1omerovic) about #SWITCHSWEDEHEART. 📊 Deathpall (@hvanspall) speaks with Prof Elmir Omerovic (@elmir1omerovic) about #SWITCHSWEDEHEART. 📊 Death, MI or stroke at 1 year: • 11.1% with a prasugr.co/70SZ0BK1uE
Uploaded
08-30-2026
ESC 2026: Fifth Universal Definition of Myocardial Infarction
ESC 2026: Fifth Universal Definition of Myocardial Infarction Prof Kristin Newby (Duke University Medical Center, Durham, ...
Tweeted
08-30-2026
Radcliffe Cardiology
@radcliffeCARDIO 🫀“The guideline approach did not yield an adequate proportion meeting those important thresholds.” At #ESC2026, Dr Harriette Van Spall (@hvanspall) speaks with Prof Gilles Montalescot about #ASpall (@hvanspall) speaks with Prof Gilles Montalescot about #AMUNDradc.life/OpSwnOLbU6xbvui4Ij 📊 82% reached LDL-C targetco/G38hafDXLG
Radcliffe Cardiology
@radcliffeCARDIO 🫀“The guideline approach did not yield an adequate proportion meeting those important thresholds.” At #ESC2026, Dr Harriette Van Spall (@hvanspall) speaks with Prof Gilles Montalescot about #ASpall (@hvanspall) speaks with Prof Gilles Montalescot about #AMUNDradc.life/OpSwnOLbU6xbvui4Ij 📊 82% reached LDL-C targetco/G38hafDXLG
Uploaded
08-30-2026
POET-II at ESC 2026: Can We Safely Shorten Endocarditis Treatment?
POET-II at ESC 2026: Can We Safely Shorten Endocarditis Treatment? Prof Henning Bundgaard (Rigshospitalet, Copenhagen, DK ...
Uploaded
08-30-2026
ESC 2026 | A-CLOSE: Clopidogrel Monotherapy After High-Risk PCI
ESC 2026 | A-CLOSE: Clopidogrel Monotherapy After High-Risk PCI Prof Byeoung-Keuk Kim (Yonsei University College of Medic ...
Uploaded
08-30-2026
PRESC1SE-MI: Faster Testing, Same ED Stay
PRESC1SE-MI: Faster Testing, Same ED Stay Late-breaker host Dr Harriette Van Spall sits down with Dr Jasper Boeddinghaus ...
Uploaded
08-30-2026
TRIC-I-HF: TTVI for Severe Tricuspid Regurgitation and HF | Prof Jörg Hausleiter
TRIC-I-HF: TTVI for Severe Tricuspid Regurgitation and HF | Prof Jörg Hausleiter TRIC-I-HF: TTVI in Severe Tricuspid Regu ...
Uploaded
08-30-2026
ESC 2026: AIR-STEMI Supports Angio-FFR-Guided Complete Revascularisation in STEMI
ESC 2026: AIR-STEMI Supports Angio-FFR-Guided Complete Revascularisation in STEMI ESC Congress 2026 - AIR-STEMI suggests ...
Tweeted
08-30-2026
Radcliffe Cardiology
@radcliffeCARDIO 📚 New #ECRJournal Article: "Lipoprotein(a) and Aortic Stenosis" 📚 Just Published! 🔓Access it here 👉 https://t.co/dtBanqYMff #MedEd #CardioEd #Vasow.ly/1v7I106CVhxo/dtBanqYMff #MedEd #CardioEd #Vasco/BPm8f6LFxS
Radcliffe Cardiology
@radcliffeCARDIO 📚 New #ECRJournal Article: "Lipoprotein(a) and Aortic Stenosis" 📚 Just Published! 🔓Access it here 👉 https://t.co/dtBanqYMff #MedEd #CardioEd #Vasow.ly/1v7I106CVhxo/dtBanqYMff #MedEd #CardioEd #Vasco/BPm8f6LFxS
Uploaded
08-29-2026
Prof Giuseppe Rosano on Key Updates to the Heart Failure Guidelines
Prof Giuseppe Rosano on Key Updates to the Heart Failure Guidelines New heart failure guidelines place greater emphasis o ...
Uploaded
08-29-2026
PRESC1SE MI ESC 0 1 Hour Algorithm in NSTEMI
PRESC1SE MI ESC 0 1 Hour Algorithm in NSTEMI Visit Radcliffe Cardiology: https://www.radcliffecardiology.com/ This conte ...
Uploaded
08-29-2026
CARDIO TTRansform Evaluates Eplontersen in ATTR-CM
CARDIO TTRansform Evaluates Eplontersen in ATTR-CM Visit Radcliffe Cardiology: https://www.radcliffecardiology.com/ This ...
Tweeted
08-29-2026
Radcliffe Cardiology
@radcliffeCARDIO 🩸 Is extended dual antiplatelet therapy always necessary after high-risk PCI? At #ESCCongress2026, Prof Byeoung-Keuk Kim discusses the A-CLOSE trial, which compared clopidogrel monotherapy with prolonged DAPT in 3,200 event-free patients following PCI with drug-eluting stentx6Q
Radcliffe Cardiology
@radcliffeCARDIO 🩸 Is extended dual antiplatelet therapy always necessary after high-risk PCI? At #ESCCongress2026, Prof Byeoung-Keuk Kim discusses the A-CLOSE trial, which compared clopidogrel monotherapy with prolonged DAPT in 3,200 event-free patients following PCI with drug-eluting stentx6Q
Tweeted
08-29-2026
Radcliffe Cardiology
@radcliffeCARDIO 🚨 ESC 2026 | New ESC CKD Guidelines What could the first ESC guidelines for cardiovascular disease and CKD mean for clinical practice? Dr Kevin Damman discusses screening, risk assessment and evidence-based cardiorenal therapies. 🔗 https://t.co/8ykxPu2PaW #ESC202ow.ly/vMjT50ZGS2rPu2PaW #ESC2026aLWWZ2
Radcliffe Cardiology
@radcliffeCARDIO 🚨 ESC 2026 | New ESC CKD Guidelines What could the first ESC guidelines for cardiovascular disease and CKD mean for clinical practice? Dr Kevin Damman discusses screening, risk assessment and evidence-based cardiorenal therapies. 🔗 https://t.co/8ykxPu2PaW #ESC202ow.ly/vMjT50ZGS2rPu2PaW #ESC2026aLWWZ2
Tweeted
08-29-2026
Radcliffe Cardiology
@radcliffeCARDIO 🎙️ Dr Van Spall & Dr Jasper Boeddinghaus discuss PRESC1SE-MI from #ESCCongress2026 Implementation of the ESC 0/1-hour pathway achieved: 📊 67,624 patient presentations 📊 Earlier repeat hs-cTn testing (190 min → 86 min) ✅ Non-inferior for death or new type 1 MI ://t.co/7vv87ugChS
Radcliffe Cardiology
@radcliffeCARDIO 🎙️ Dr Van Spall & Dr Jasper Boeddinghaus discuss PRESC1SE-MI from #ESCCongress2026 Implementation of the ESC 0/1-hour pathway achieved: 📊 67,624 patient presentations 📊 Earlier repeat hs-cTn testing (190 min → 86 min) ✅ Non-inferior for death or new type 1 MI ://t.co/7vv87ugChS
Tweeted
08-29-2026
Radcliffe Cardiology
@radcliffeCARDIO 🚨 HOT LINE TAKEAWAY | CARDIO-TTRansform A neutral trial, but not the end of the story. Dr Margot Davis explains the full ESC 2026 CARDIO-TTRansform results and what they reveal about: ✅ Eplontersen as monotherapy ✅ The role of background tafamidis therapy ✅3zjYoBtX6
Radcliffe Cardiology
@radcliffeCARDIO 🚨 HOT LINE TAKEAWAY | CARDIO-TTRansform A neutral trial, but not the end of the story. Dr Margot Davis explains the full ESC 2026 CARDIO-TTRansform results and what they reveal about: ✅ Eplontersen as monotherapy ✅ The role of background tafamidis therapy ✅3zjYoBtX6
Tweeted
08-29-2026
Radcliffe Cardiology
@radcliffeCARDIO 🚨 ESC 2026 | SWITCH SWEDEHEART: Prasugrel vs Tcagrelor Could P2Y12 inhibitor selection in acute coronary syndrome be changing? Prof Elmir Omerovic discusses SWITCH SWEDEHEART, which enrolled 17,095 patients and compared prasugrel and ticagrelor. 🔗 Watch the full inter9Q0yZ7
Radcliffe Cardiology
@radcliffeCARDIO 🚨 ESC 2026 | SWITCH SWEDEHEART: Prasugrel vs Tcagrelor Could P2Y12 inhibitor selection in acute coronary syndrome be changing? Prof Elmir Omerovic discusses SWITCH SWEDEHEART, which enrolled 17,095 patients and compared prasugrel and ticagrelor. 🔗 Watch the full inter9Q0yZ7
Tweeted
08-29-2026
Radcliffe Cardiology
@radcliffeCARDIO 🚨 ESC 2026 | STAREE Investigates Statins for Healthy Adults Aged ≥70 Years Can statins improve outcomes in healthy adults aged ≥70 Years? Prof Sophia Zoungas discusses STAREE, which enrolled 9,971 participants and evaluated atorvastatin 40 mg versus placebo. 🔗 UEDx46mzGw
Radcliffe Cardiology
@radcliffeCARDIO 🚨 ESC 2026 | STAREE Investigates Statins for Healthy Adults Aged ≥70 Years Can statins improve outcomes in healthy adults aged ≥70 Years? Prof Sophia Zoungas discusses STAREE, which enrolled 9,971 participants and evaluated atorvastatin 40 mg versus placebo. 🔗 UEDx46mzGw
